Compare commits
6 commits
44633d9a46
...
be0ebe2608
| Author | SHA1 | Date | |
|---|---|---|---|
|
|
be0ebe2608 | ||
| c53047304f | |||
|
|
be7a360d38 | ||
|
|
458aa7494e | ||
| 54869f7e31 | |||
|
|
994f00fe77 |
12 changed files with 105 additions and 34 deletions
|
|
@ -37,20 +37,14 @@ This advantage compounds with the scarcity economics documented in the media att
|
|||
- **Human-made premium unquantified**: The underlying premium itself is still emerging and not yet measured
|
||||
- **Selection bias risk**: Communities may form preferentially around human-created content for reasons other than provenance (quality, cultural resonance), confounding causality
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-06-02-kidscreen-mediawan-claynosaurz-animated-series]] | Added: 2026-03-15*
|
||||
|
||||
Community-owned IP has a second structural advantage beyond provenance: pre-existing distribution reach. Claynosaurz's ~1B views across social platforms provides guaranteed launch audience that traditional IP development cannot match, enabling YouTube-first distribution strategy that generates performance data before traditional buyer commitment. This distribution advantage compounds with provenance advantage—community IP is both verifiably human-made AND comes with built-in audience.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
- human-made is becoming a premium label analogous to organic as AI-generated content becomes dominant
|
||||
- [[human-made is becoming a premium label analogous to organic as AI-generated content becomes dominant]]
|
||||
- [[the media attractor state is community-filtered IP with AI-collapsed production costs where content becomes a loss leader for the scarce complements of fandom community and ownership]]
|
||||
- [[entertainment IP should be treated as a multi-sided platform that enables fan creation rather than a unidirectional broadcast asset]]
|
||||
- [[progressive validation through community building reduces development risk by proving audience demand before production investment]]
|
||||
|
||||
Topics:
|
||||
- [[entertainment]]
|
||||
- cultural-dynamics
|
||||
- [[cultural-dynamics]]
|
||||
|
|
@ -29,6 +29,12 @@ This decision follows Claynosaurz's demonstrated 450M+ views, 200M+ impressions,
|
|||
|
||||
This is one data point from one studio. The claim is experimental because it's based on a single co-production decision. Broader pattern confirmation would require multiple independent studios making similar choices. Also unclear whether YouTube-first is driven by community validation specifically or by other factors (budget, Mediawan's strategic positioning, YouTube's kids content strategy).
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-06-02-kidscreen-mediawan-claynosaurz-animated-series]] | Added: 2026-03-15*
|
||||
|
||||
The Claynosaurz-Mediawan co-production will launch on YouTube first, then sell to TV and streaming buyers. This inverts the traditional risk model: YouTube launch proves audience metrics before traditional buyers commit, using the community's existing social reach (~1B views) as a guaranteed launch audience. Mediawan brings professional production quality while the community provides distribution validation, creating a new risk-sharing structure where platform distribution precedes rather than follows traditional media deals.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -27,6 +27,12 @@ This is not an American problem alone. The American diet and lifestyle are sprea
|
|||
|
||||
The four major risk factors behind the highest burden of noncommunicable disease -- tobacco use, harmful use of alcohol, unhealthy diets, and physical inactivity -- are all lifestyle factors that simple interventions could address. The gap between what science knows works (lifestyle modification) and what the system delivers (pharmaceutical symptom management) represents one of the largest misalignments in the modern economy.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-06-01-cell-med-glp1-societal-implications-obesity]] | Added: 2026-03-15*
|
||||
|
||||
GLP-1s may function as a pharmacological counter to engineered food addiction. The population-level obesity decline (39.9% to 37.0%) coinciding with 12.4% adult GLP-1 adoption suggests pharmaceutical intervention can partially offset the metabolic consequences of engineered hyperpalatable foods, though this addresses symptoms rather than root causes of the food environment.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -23,6 +23,12 @@ The competitive dynamics (Lilly vs. Novo vs. generics post-2031) will drive pric
|
|||
|
||||
Real-world persistence data from 125,474 commercially insured patients shows the chronic use model fails not because patients choose indefinite use, but because most cannot sustain it: only 32.3% of non-diabetic obesity patients remain on GLP-1s at one year, dropping to approximately 15% at two years. This creates a paradox for payer economics—the "inflationary chronic use" concern assumes sustained adherence, but the actual problem is insufficient persistence. Under capitation, payers pay for 12 months of therapy ($2,940 at $245/month) for patients who discontinue and regain weight, capturing net cost with no downstream savings from avoided complications. The economics only work if adherence is sustained AND the payer captures downstream benefits—with 85% discontinuing by two years, the downstream cardiovascular and metabolic savings that justify the cost never materialize for most patients.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-06-01-cell-med-glp1-societal-implications-obesity]] | Added: 2026-03-15*
|
||||
|
||||
The Cell Press review characterizes GLP-1s as marking a 'system-level redefinition' of cardiometabolic management with 'ripple effects across healthcare costs, insurance models, food systems, long-term population health.' Obesity costs the US $400B+ annually, providing context for the scale of potential cost impact. The WHO issued conditional recommendations within 2 years of widespread adoption (December 2025), unusually fast for a major therapeutic category.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -31,6 +31,12 @@ Since specialization and value form an autocatalytic feedback loop where each am
|
|||
|
||||
The Commonwealth Fund's 2024 international comparison demonstrates this transition empirically across 10 developed nations. All countries compared (Australia, Canada, France, Germany, Netherlands, New Zealand, Sweden, Switzerland, UK, US) have eliminated material scarcity in healthcare — all possess advanced clinical capabilities and universal or near-universal access infrastructure. Yet health outcomes vary dramatically. The US spends >16% of GDP (highest by far) with worst outcomes, while top performers (Australia, Netherlands) spend the lowest percentage of GDP. The differentiator is not clinical capability (US ranks 2nd in care process quality) but access structures and equity — social determinants. This proves that among developed nations with sufficient material resources, social disadvantage (who gets care, discrimination, equity barriers) drives outcomes more powerfully than clinical quality or spending volume.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-06-01-cell-med-glp1-societal-implications-obesity]] | Added: 2026-03-15*
|
||||
|
||||
GLP-1 access inequality demonstrates the epidemiological transition in action: the intervention addresses metabolic disease (post-transition health problem) but access stratifies by wealth and insurance status (social disadvantage), potentially widening health inequalities even as population-level outcomes improve. The WHO's emphasis on 'multisectoral action' and 'healthier environments' acknowledges that pharmaceutical solutions alone cannot address socially-determined health outcomes.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -97,6 +97,12 @@ MetaDAO ICO platform processed 8 projects from April 2025 to January 2026, raisi
|
|||
|
||||
MetaDAO Q3 2024 roadmap prioritized launching a market-based grants product as the primary objective, with specific targets to launch 5 organizations and process 8 proposals through the product. This represents an expansion from pure ICO functionality to grants decision-making, demonstrating futarchy's application to capital allocation beyond fundraising.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-04-09-blockworks-ranger-ico-metadao-reset]] | Added: 2026-03-15*
|
||||
|
||||
Ranger Finance ICO completed in April 2025, adding ~$9.1M to total Assets Under Futarchy, bringing the total to $57.3M across 10 launched projects. This represents continued momentum in futarchy-governed capital formation, with Ranger being a leveraged trading platform on Solana. The article also notes MetaDAO was 'considering strategic changes to its platform model' around this time, though details were not specified.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -49,6 +49,7 @@ MetaDAO's token launch platform. Implements "unruggable ICOs" — permissionless
|
|||
- **2026-03-05** — [[insert-coin-labs-futardio-fundraise]] launched for Web3 gaming studio (failed, $2,508 / $50K = 5% of target)
|
||||
- **2026-03-05** — [[git3-futardio-fundraise]] failed: Git3 raised $28,266 of $100K target (28.3%) before entering refunding status, demonstrating market filtering even with live MVP
|
||||
- **2024-06-14** — [[futardio-fund-rug-bounty-program]] passed: Approved $5K USDC funding for RugBounty.xyz platform development to incentivize community recovery from rug pulls
|
||||
- **2024-08-28** — MetaDAO proposal to develop futardio as memecoin launchpad with futarchy governance failed. Proposal would have allocated $100k grant over 6 months to development team. Key features: percentage of each new token supply allocated to futarchy DAO, points-to-token conversion within 180 days, revenue distribution to $FUTA holders, immutable deployment on IPFS/Arweave. Proposal rejected by market, suggesting reputational risks outweighed adoption benefits.
|
||||
## Competitive Position
|
||||
- **Unique mechanism**: Only launch platform with futarchy-governed accountability and treasury return guarantees
|
||||
- **vs pump.fun**: pump.fun is memecoin launch (zero accountability, pure speculation). Futardio is ownership coin launch (futarchy governance, treasury enforcement). Different categories despite both being "launch platforms."
|
||||
|
|
|
|||
|
|
@ -0,0 +1,32 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "glp-1-adoption-produced-first-measurable-population-level-obesity-decline-demonstrating-pharmaceutical-intervention-can-shift-population-health-outcomes.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "glp-1-access-inequality-risks-creating-two-tier-metabolic-health-system-where-pharmacological-prevention-stratifies-by-wealth-while-root-causes-remain-unaddressed.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 2,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"glp-1-adoption-produced-first-measurable-population-level-obesity-decline-demonstrating-pharmaceutical-intervention-can-shift-population-health-outcomes.md:set_created:2026-03-15",
|
||||
"glp-1-access-inequality-risks-creating-two-tier-metabolic-health-system-where-pharmacological-prevention-stratifies-by-wealth-while-root-causes-remain-unaddressed.md:set_created:2026-03-15"
|
||||
],
|
||||
"rejections": [
|
||||
"glp-1-adoption-produced-first-measurable-population-level-obesity-decline-demonstrating-pharmaceutical-intervention-can-shift-population-health-outcomes.md:missing_attribution_extractor",
|
||||
"glp-1-access-inequality-risks-creating-two-tier-metabolic-health-system-where-pharmacological-prevention-stratifies-by-wealth-while-root-causes-remain-unaddressed.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-15"
|
||||
}
|
||||
|
|
@ -1,34 +1,25 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "co-production-preserves-community-ip-control-while-accessing-professional-infrastructure-unlike-licensing-which-cedes-distribution-rights.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "youtube-first-launch-proves-audience-metrics-before-traditional-distribution-commitment-inverting-broadcast-first-risk-model.md",
|
||||
"filename": "co-production-preserves-community-ip-control-while-accessing-traditional-production-infrastructure.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"total": 1,
|
||||
"kept": 0,
|
||||
"fixed": 6,
|
||||
"rejected": 2,
|
||||
"fixed": 4,
|
||||
"rejected": 1,
|
||||
"fixes_applied": [
|
||||
"co-production-preserves-community-ip-control-while-accessing-professional-infrastructure-unlike-licensing-which-cedes-distribution-rights.md:set_created:2026-03-15",
|
||||
"co-production-preserves-community-ip-control-while-accessing-professional-infrastructure-unlike-licensing-which-cedes-distribution-rights.md:stripped_wiki_link:progressive-validation-through-community-building-reduces-de",
|
||||
"co-production-preserves-community-ip-control-while-accessing-professional-infrastructure-unlike-licensing-which-cedes-distribution-rights.md:stripped_wiki_link:traditional-media-buyers-now-seek-content-with-pre-existing-",
|
||||
"youtube-first-launch-proves-audience-metrics-before-traditional-distribution-commitment-inverting-broadcast-first-risk-model.md:set_created:2026-03-15",
|
||||
"youtube-first-launch-proves-audience-metrics-before-traditional-distribution-commitment-inverting-broadcast-first-risk-model.md:stripped_wiki_link:progressive-validation-through-community-building-reduces-de",
|
||||
"youtube-first-launch-proves-audience-metrics-before-traditional-distribution-commitment-inverting-broadcast-first-risk-model.md:stripped_wiki_link:traditional-media-buyers-now-seek-content-with-pre-existing-"
|
||||
"co-production-preserves-community-ip-control-while-accessing-traditional-production-infrastructure.md:set_created:2026-03-15",
|
||||
"co-production-preserves-community-ip-control-while-accessing-traditional-production-infrastructure.md:stripped_wiki_link:community-owned-IP-has-structural-advantage-in-human-made-pr",
|
||||
"co-production-preserves-community-ip-control-while-accessing-traditional-production-infrastructure.md:stripped_wiki_link:progressive-validation-through-community-building-reduces-de",
|
||||
"co-production-preserves-community-ip-control-while-accessing-traditional-production-infrastructure.md:stripped_wiki_link:traditional-media-buyers-now-seek-content-with-pre-existing-"
|
||||
],
|
||||
"rejections": [
|
||||
"co-production-preserves-community-ip-control-while-accessing-professional-infrastructure-unlike-licensing-which-cedes-distribution-rights.md:missing_attribution_extractor",
|
||||
"youtube-first-launch-proves-audience-metrics-before-traditional-distribution-commitment-inverting-broadcast-first-risk-model.md:missing_attribution_extractor"
|
||||
"co-production-preserves-community-ip-control-while-accessing-traditional-production-infrastructure.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2025-04-09
|
|||
domain: internet-finance
|
||||
secondary_domains: []
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: medium
|
||||
tags: [metadao, ranger-finance, ICO, assets-under-futarchy, ownership-coins]
|
||||
processed_by: rio
|
||||
processed_date: 2026-03-15
|
||||
enrichments_applied: ["MetaDAO is the futarchy launchpad on Solana where projects raise capital through unruggable ICOs governed by conditional markets creating the first platform for ownership coins at scale.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -43,3 +47,11 @@ tags: [metadao, ranger-finance, ICO, assets-under-futarchy, ownership-coins]
|
|||
PRIMARY CONNECTION: [[MetaDAO is the futarchy launchpad on Solana where projects raise capital through unruggable ICOs governed by conditional markets creating the first platform for ownership coins at scale]]
|
||||
WHY ARCHIVED: Latest AUF figure ($57.3M) and "strategic reset" signal worth tracking
|
||||
EXTRACTION HINT: The AUF metric is data for updating existing claims; the "strategic reset" needs follow-up investigation
|
||||
|
||||
|
||||
## Key Facts
|
||||
- MetaDAO total Assets Under Futarchy reached $57.3M as of April 9, 2025
|
||||
- Ranger Finance ICO added approximately $9.1M to MetaDAO's AUF
|
||||
- MetaDAO has launched 10 projects to date as of April 2025
|
||||
- MetaDAO ICO sales use a 4-day deposit period with USDC
|
||||
- MetaDAO was considering a 'strategic reset' to its platform model in April 2025
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2025-06-01
|
|||
domain: health
|
||||
secondary_domains: [entertainment, internet-finance]
|
||||
format: paper
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: medium
|
||||
tags: [glp-1, obesity, societal-impact, equity, food-systems, population-health, sustainability]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-15
|
||||
enrichments_applied: ["GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md", "Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated.md", "the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -52,3 +56,11 @@ EXTRACTION HINT: Focus on both the population-level effect AND the equity concer
|
|||
|
||||
flagged_for_clay: ["GLP-1 adoption is reshaping cultural narratives around obesity, body image, and pharmaceutical solutions to behavioral problems — connects to health narrative infrastructure"]
|
||||
flagged_for_rio: ["GLP-1 equity gap creates investment opportunity in access-focused models that serve underserved populations — potential Living Capital thesis"]
|
||||
|
||||
|
||||
## Key Facts
|
||||
- October 2025 Gallup poll: 12.4% of US adults taking GLP-1 for weight loss (30M+ people)
|
||||
- US obesity prevalence: 39.9% (2022) → 37.0% (2025), representing 7.6M fewer obese Americans
|
||||
- WHO issued conditional recommendations for GLP-1s in December 2025
|
||||
- Obesity costs US $400B+ annually
|
||||
- WHO three-pillar approach: healthier environments (population policy), protect high-risk individuals, person-centered care
|
||||
|
|
|
|||
|
|
@ -12,7 +12,7 @@ priority: medium
|
|||
tags: [claynosaurz, mediawan, animated-series, youtube-distribution, community-ip, co-production]
|
||||
processed_by: clay
|
||||
processed_date: 2026-03-15
|
||||
enrichments_applied: ["community-owned-IP-has-structural-advantage-in-human-made-premium-because-provenance-is-inherent-and-legible.md"]
|
||||
enrichments_applied: ["youtube-first-distribution-for-major-studio-coproductions-signals-platform-primacy-over-traditional-broadcast-windowing.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
|
|
@ -55,9 +55,8 @@ EXTRACTION HINT: Two distinct claims: (1) co-production vs licensing as structur
|
|||
|
||||
|
||||
## Key Facts
|
||||
- Claynosaurz animated series: 39 episodes x 7 minutes each
|
||||
- Claynosaurz-Mediawan deal is for 39 episodes of 7 minutes each
|
||||
- Claynosaurz community has generated ~1 billion views across social platforms
|
||||
- Method Animation is a Mediawan subsidiary handling production
|
||||
- Deal was presented at Annecy International Animation Festival 2025
|
||||
- Paw Patrol is a $10B+ franchise
|
||||
- Distribution sequence: YouTube launch first, then TV and streaming sales
|
||||
- Deal was presented at Annecy International Animation Festival in June 2025
|
||||
- Paw Patrol creator visited to understand the community-first production model
|
||||
- Mediawan and Gameloft CEOs engaged directly with Claynosaurz community token holders
|
||||
|
|
|
|||
Loading…
Reference in a new issue